{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:10:52Z","timestamp":1781241052738,"version":"3.54.1"},"reference-count":61,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T00:00:00Z","timestamp":1304899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Tumour lysis syndrome (TLS) is caused by the disintegration of malignant cells, usually following the instigation of chemotherapy, although it may already be established at the time of initial presentation in a minority of cases. As a direct consequence of malignant cell breakdown, intracellular ions, proteins, nucleic acids and their metabolites are released into the plasma causing the characteristic metabolic abnormalities of TLS; hyperuricaemia, hyperkalaemia, hyperphosphataemia and hypocalcaemia. In many cases the release of large amounts intracellular contents is so abrupt that the normal homeostatic mechanisms are rapidly overwhelmed and without prompt, effective management, the clinical effects of TLS soon become apparent.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2011.08697.x","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T10:47:11Z","timestamp":1305024431000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The clinical management of tumour lysis syndrome in haematological malignancies"],"prefix":"10.1111","volume":"154","author":[{"given":"Andrew","family":"Will","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tholouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,9]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120004100"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80387-0"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000054661"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.379"},{"key":"e_1_2_15_6_1","first-page":"1700","article-title":"Akutar Harnleiterverschluss nach Bertrahlung chronischer Leuk\u00e4mien mit R\u00f6ntgenstrahlen","volume":"25","author":"Bedrna J.","year":"1929","journal-title":"Medizinische Klinik"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-200027656"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11612"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1252"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1188\/02.CJON.12-16"},{"key":"e_1_2_15_11_1","first-page":"890","article-title":"Enzymatic uricolysis: a study of the effect of a fungal uric oxidase","volume":"17","author":"Brogard J.M.","year":"1972","journal-title":"Revues Europeenne d\u2019 Etudes Cliniques et Bioliologiques"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G272"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2002.s.012"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.4.83"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.003"},{"key":"e_1_2_15_18_1","first-page":"117","article-title":"Managing malignancy\u2010associated hyperuricemia with rasburicase","volume":"3","author":"Cheson B.D.","year":"2005","journal-title":"The Journal of Supportive Oncology"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30522-3"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108700"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<85::AID-AJH15>3.0.CO;2-9"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.045"},{"key":"e_1_2_15_24_1","first-page":"189","article-title":"Peritoneal dialysis in acute uric acid nephropathy","volume":"47","author":"Deger G.E.","year":"1972","journal-title":"Mayo Clinic Proceeding"},{"key":"e_1_2_15_25_1","first-page":"89","article-title":"Hemolytic anaemia due to G6PD deficiency and urate oxidase in a kidney transplant patient","volume":"35","author":"Ducros J.","year":"1991","journal-title":"Clinical Nephrology"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200103060-00004"},{"key":"e_1_2_15_27_1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.V79.4.871.bloodjournal794871","article-title":"Complications and outcome in childhood acute lymphoblastic leukaemia with hyperleukocytosis","volume":"79","author":"Eguiguren J.M.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_15_28_1","first-page":"322","article-title":"Metabolic emergencies in the cancer patient","volume":"27","author":"Flombaum C.D.","year":"2000","journal-title":"Seminars in Oncology"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.2998"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90174-N"},{"key":"e_1_2_15_31_1","first-page":"2273","article-title":"Postchemotherapy purine excretion in lymphoma patients receiving allopurinol","volume":"41","author":"Hande K.R.","year":"1981","journal-title":"Cancer Research"},{"key":"e_1_2_15_32_1","first-page":"50","article-title":"Acute spontaneous tumor lysis syndrome presenting with hyperuricemic renal failure: clinical features and therapeutic approach","volume":"17","author":"Hsu H.H.","year":"2004","journal-title":"Journal of Nephrology"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470212"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90037-X"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403566"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00860751"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03090010007001"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90358-K"},{"key":"e_1_2_15_39_1","doi-asserted-by":"crossref","unstructured":"Locatelli F.&Rossi F.(2005).Incidence and pathogenesis of tumor lysis syndrome.Contributions to nephrology 147 pp.61\u201368.","DOI":"10.1159\/000082543"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900715)66:2<246::AID-CNCR2820660209>3.0.CO;2-B"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11575"},{"key":"e_1_2_15_42_1","first-page":"161","article-title":"Pharmacological treatment of acute renal failure in intensive care patients","volume":"147","author":"Moreau D.","year":"2005","journal-title":"Contributions to Nephrology"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402847"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf134"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904252"},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/674908"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.4.433"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400850"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.3.697"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0581"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2003.n.003"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(01)90255-6"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.2000.1118"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02049870"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2009.tb02721.x"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900301)65:5<1072::AID-CNCR2820650504>3.0.CO;2-A"},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-976175"},{"key":"e_1_2_15_58_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","article-title":"Incidence of tumor lysis syndrome in children with advanced stage Burkitt\u2019s lymphoma\/leukemia before and after induction of prophylactic use of urate oxidase","volume":"82","author":"W\u00f6ssmann W.","year":"2003","journal-title":"Annals of Hematology"},{"key":"e_1_2_15_59_1","first-page":"52","article-title":"Acute tumor lysis syndrome caused by palliative radiotherapy in patients with diffuse large B\u2010cell lymphoma","volume":"22","author":"Yamazaki H.","year":"2004","journal-title":"Radiation Medicine"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<247::AID-AJH9>3.0.CO;2-T"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90622-I"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197312202892503"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.08697.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08697.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:41:06Z","timestamp":1697380866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.08697.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,9]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1365-2141.2011.08697.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08697.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,9]]},"assertion":[{"value":"2011-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}